Literature DB >> 7568241

Direct observation of disordered regions in the major histocompatibility complex class II-associated invariant chain.

A Jasanoff1, S J Park, D C Wiley.   

Abstract

Invariant chain (Ii) is a trimeric membrane protein which binds and stabilizes major histocompatibility complex class II heterodimers in the endoplasmic reticulum and lysosomal compartments of antigen-presenting cells. In concert with an intracellular class II-like molecule, HLA-DM, Ii seems to facilitate loading of conventional class II molecules with peptides before transport of the class II-peptide complex to the cell surface for recognition by T cells. The interaction of Ii with class II molecules is thought to be mediated in large part through a region of 24 amino acids (the class II-associated Ii peptide, CLIP) which binds as a cleaved moiety in the antigenic peptide-binding groove of class II molecules in HLA-DM-deficient cell lines. Here we use nuclear magnetic resonance techniques to demonstrate that a soluble recombinant Ii ectodomain contains significant disordered regions which probably include CLIP.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7568241      PMCID: PMC40910          DOI: 10.1073/pnas.92.21.9900

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways.

Authors:  L Teyton; D O'Sullivan; P W Dickson; V Lotteau; A Sette; P Fink; P A Peterson
Journal:  Nature       Date:  1990-11-01       Impact factor: 49.962

2.  Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules.

Authors:  P A Roche; P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-15       Impact factor: 11.205

3.  Formation of a nine-subunit complex by HLA class II glycoproteins and the invariant chain.

Authors:  P A Roche; M S Marks; P Cresswell
Journal:  Nature       Date:  1991-12-05       Impact factor: 49.962

4.  Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding.

Authors:  P A Roche; P Cresswell
Journal:  Nature       Date:  1990-06-14       Impact factor: 49.962

5.  Dynamics of the multidomain fibrinolytic protein urokinase from two-dimensional NMR.

Authors:  R E Oswald; M J Bogusky; M Bamberger; R A Smith; C M Dobson
Journal:  Nature       Date:  1989-02-09       Impact factor: 49.962

6.  Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation.

Authors:  D C Wiley; I A Wilson; J J Skehel
Journal:  Nature       Date:  1981-01-29       Impact factor: 49.962

7.  Mobility of polypeptide chain in the pyruvate dehydrogenase complex revealed by proton NMR.

Authors:  R N Perham; H W Duckworth; G C Roberts
Journal:  Nature       Date:  1981-07-30       Impact factor: 49.962

8.  Human growth hormone and extracellular domain of its receptor: crystal structure of the complex.

Authors:  A M de Vos; M Ultsch; A A Kossiakoff
Journal:  Science       Date:  1992-01-17       Impact factor: 47.728

9.  Invariant chain associates with HLA class II antigens via its extracytoplasmic region.

Authors:  M S Marks; P Cresswell
Journal:  J Immunol       Date:  1986-04-01       Impact factor: 5.422

10.  Invariant chain trimers are sequestered in the rough endoplasmic reticulum in the absence of association with HLA class II antigens.

Authors:  M S Marks; J S Blum; P Cresswell
Journal:  J Cell Biol       Date:  1990-09       Impact factor: 10.539

View more
  14 in total

1.  Structure of a trimeric domain of the MHC class II-associated chaperonin and targeting protein Ii.

Authors:  A Jasanoff; G Wagner; D C Wiley
Journal:  EMBO J       Date:  1998-12-01       Impact factor: 11.598

2.  Functionality of major histocompatibility complex class II molecules in mice doubly deficient for invariant chain and H-2M complexes.

Authors:  S Tourne; T Miyazaki; P Wolf; H Ploegh; C Benoist; D Mathis
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-19       Impact factor: 11.205

Review 3.  Ancient features of the MHC class II presentation pathway, and a model for the possible origin of MHC molecules.

Authors:  Johannes M Dijkstra; Takuya Yamaguchi
Journal:  Immunogenetics       Date:  2018-10-30       Impact factor: 2.846

4.  Invariant chain made in Escherichia coli has an exposed N-terminal segment that blocks antigen binding to HLA-DR1 and a trimeric C-terminal segment that binds empty HLA-DR1.

Authors:  S J Park; S Sadegh-Nasseri; D C Wiley
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-21       Impact factor: 11.205

5.  Modeling of both shared and distinct interactions between MIF and its homologue D-DT with their common receptor CD74.

Authors:  Roberto Meza-Romero; Gil Benedek; Kelley Jordan; Lin Leng; Georgios Pantouris; Elias Lolis; Richard Bucala; Arthur A Vandenbark
Journal:  Cytokine       Date:  2016-08-27       Impact factor: 3.861

Review 6.  Conformational variation in structures of classical and non-classical MHCII proteins and functional implications.

Authors:  Corrie A Painter; Lawrence J Stern
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

7.  An Analysis of MIF Structural Features that Control Functional Activation of CD74.

Authors:  Georgios Pantouris; Mansoor Ali Syed; Chengpeng Fan; Deepa Rajasekaran; Thomas Yoonsang Cho; Eric M Rosenberg; Richard Bucala; Vineet Bhandari; Elias J Lolis
Journal:  Chem Biol       Date:  2015-09-10

8.  An asymmetric deuterium labeling strategy to identify interprotomer and intraprotomer NOEs in oligomeric proteins.

Authors:  A Jasanoff
Journal:  J Biomol NMR       Date:  1998-08       Impact factor: 2.835

9.  Stoichiometry of HLA class II-invariant chain oligomers.

Authors:  Norbert Koch; Martin Zacharias; Angelika König; Sebastian Temme; Jürgen Neumann; Sebastian Springer
Journal:  PLoS One       Date:  2011-02-22       Impact factor: 3.240

Review 10.  Partnering for the major histocompatibility complex class II and antigenic determinant requires flexibility and chaperons.

Authors:  Scheherazade Sadegh-Nasseri
Journal:  Curr Opin Immunol       Date:  2021-06-17       Impact factor: 7.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.